KPV is a short synthetic tripeptide (Lysine-Proline-Valine) derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), studied primarily in laboratory settings for its anti-inflammatory signaling properties independent of melanocortin receptor activation. Because it's a very small peptide sequence, sourcing it well is less about a single synthesis quirk and more about the same fundamentals that apply to any short research peptide: verified purity, confirmed identity, and batch-level documentation that a lab can actually cite.
Minimum specifications to look for
- Purity ≥98% by HPLC — the analytical method should be named on the Certificate of Analysis, not just a number printed on a label. See HPLC purity analysis.
- Identity confirmed by mass spectrometry — KPV's short three-residue sequence makes it easy to synthesize but also easy to mislabel; mass spec confirmation is what verifies the molecule in the vial actually matches the stated sequence. See HPLC vs. mass spectrometry.
- Batch-specific Certificate of Analysis — tied to the exact lot shipped, not a template document reused across runs. See how to read a COA.
- Net peptide content disclosed — the labeled vial mass includes counter-ions and residual moisture in addition to peptide; suppliers who separate labeled mass from net peptide content are giving labs an accurate accounting of what's actually being weighed out.
- Lyophilized form with proper storage guidance — KPV should ship as a stable lyophilized powder with clear reconstitution and cold-chain direction. See KPV reconstitution and storage.
KPV vs. GHK-KPV: know which one you're sourcing
KPV is sold both as the standalone tripeptide and combined with the copper-binding tripeptide GHK into the hybrid GHK-KPV compound. These are chemically distinct research materials with different molecular weights and different research literature behind them, and a supplier's product listing should make unambiguously clear which one is in the vial — not use the names interchangeably in marketing copy. If a listing is vague about which sequence is actually being sold, that's a documentation gap, not a minor detail.
Evaluating a supplier
A practical framework for vetting any KPV supplier comes down to a handful of direct questions:
- Is the Certificate of Analysis issued per batch, or is the same document reused across multiple production runs?
- Was purity and identity testing performed in-house, by an independent third-party lab, or both? See third-party testing explained.
- Does the listing clearly distinguish standalone KPV from the GHK-KPV combination, with separate documentation for each?
- Are the terms of sale explicitly research-use-only, with no dosing or usage instructions implying anything else?
- Does the vial size and labeled mass match what's described on both the product page and the COA?
Suppliers with nothing to hide typically answer these plainly and can produce documentation on request. Vague answers, refusal to provide a batch-specific COA, or pressure to skip these questions are all reasons to look elsewhere.
Price as a signal, not just a cost
KPV pricing that sits dramatically below the market range for HPLC-verified, mass-spec-confirmed, batch-documented material is worth investigating rather than treating as a bargain. Analytical testing, proper Fmoc solid-phase synthesis, and legitimate cold-chain shipping all cost money; a price that leaves no room for any of that usually means a step was skipped somewhere in the process.
Quantity and shipping considerations
Labs running ongoing KPV protocols should plan around consistent batch sourcing rather than one-off purchases from different suppliers, since even legitimate batch-to-batch variation exists and mixing sources mid-protocol makes that variation harder to control for. Shipping should be handled appropriately for a lyophilized peptide reagent — domestic suppliers with straightforward, tracked shipping reduce both transit time and handling uncertainty compared to international orders that may sit in customs.
Where to buy documented KPV
V8 Peptides supplies KPV as a lyophilized powder verified to ≥98% purity by HPLC, with mass-spectrometry-confirmed identity and a batch-specific Certificate of Analysis included with every order, shipped domestically via USPS. The standalone vial is available on the KPV research vial product page, and the combination compound is available on the GHK-KPV research vial product page. For background on the compound's research profile, see the KPV research overview and the KPV vs. alpha-MSH melanocortin comparison, and the general supplier checklist for sourcing criteria that apply across any research peptide purchase.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.